Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynamic Pharmaceuticals Invesco ETF (NY: PJP )

85.61 +0.94 (+1.11%)
Official Closing Price Updated: 4:10 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,095
Open 84.78
Bid (Size) 84.08 (24)
Ask (Size) 87.85 (23)
Prev. Close 84.68
Today's Range 84.78 - 85.66
52wk Range 69.53 - 89.87
Shares Outstanding 32,200
Dividend Yield 0.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency. 
Via Benzinga
Topics Government
Exposures Political Product Safety
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak. 
Via Benzinga
Topics ETFs
Exposures COVID-19 Product Safety

Performance

YTD
+11.99%
+11.99%
1 Month
-1.96%
-1.96%
3 Month
-1.89%
-1.89%
6 Month
+6.18%
+6.18%
1 Year
+22.31%
+22.31%

More News

Read More
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Via Benzinga
Exposures COVID-19
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
A Look At Pharma ETFs After Q4 Earnings
Via Talk Markets
Topics ETFs
Government-granted Patent Monopolies Are Not The Free Market
Via Talk Markets
Topics Intellectual Property
Exposures Intellectual Property
Time For Gilead Sciences-Heavy ETFs?
Via Talk Markets
Pharma ETFs in Focus Post Q2 Earnings
Via Talk Markets
Topics ETFs
Want to Invest in Pharmaceutical Stocks but Don't Know How? Try This ETF.
Via The Motley Fool
Pharma ETFs Gain Post Q1 Earnings
Via Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
Via Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
Via Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
Via Talk Markets
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Via Talk Markets
Exposures COVID-19 Product Safety
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
Via Talk Markets
Exposures COVID-19
3 Cheap Pharmaceutical Stocks to Grab Now
Via Talk Markets
Exposures COVID-19
Pharma ETFs in Focus Post Q1 Earnings
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.